"Patients with interstitial lung disease associated pulmonary hypertension" research hub

Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)

This study is looking at a new medicine for people with high blood pressure in their lungs, caused by a lung condition. It wants to see if the medicine is safe, how the body handles it, and if it helps. It's an early-stage study.